- Trials with a EudraCT protocol (32)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (52)
32 result(s) found for: Magnesium lactate.
Displaying page 1 of 2.
EudraCT Number: 2015-003749-24 | Sponsor Protocol Number: MGLACC07810 | Start Date*: 2016-03-03 |
Sponsor Name:Sanofi-Aventis Group | ||
Full Title: Effects of MagneB6® (470.0 mg Magnesium Lactate Dihydrate + 5.0 mg Pyridoxine Hydrochloride, Coated Tablet) Supplementation (8 Weeks) on Stress Levels of Chronically Stressed Subjects, with Subopti... | ||
Medical condition: | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002041-12 | Sponsor Protocol Number: SMF 1437 | Start Date*: 2004-11-01 |
Sponsor Name:Gambro Lundia AB, Corporate Research | ||
Full Title: Is it possible to increase free sodium removal by the use of low sodium peritoneal dialysis solution? | ||
Medical condition: Subjects with renal failure treated with peritoneal dialysis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-009427-11 | Sponsor Protocol Number: PD-NL-04-EU | Start Date*: 2010-10-13 | |||||||||||
Sponsor Name:Fresenius Medical Care Deutschland GmbH | |||||||||||||
Full Title: Efecto de la solución de diálisis peritoneal balance sobre la membrana peritoneal de pacientes tratados con diálisis peritoneal automatizada (DPA) (The effect of balance peritoneal dialysis solutio... | |||||||||||||
Medical condition: Pacientes con enfermedad renal crónica tratados con diálisis peritoneal | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001394-29 | Sponsor Protocol Number: 31998 | Start Date*: 2007-12-28 | |||||||||||
Sponsor Name:Baxter Healthcare Corporation | |||||||||||||
Full Title: Multi-center, prospective trial to demonstrate Improved Metabolic control of PPEN vs DDDD in DIAbetic CAPD patients -The IMPENDIA Trial | |||||||||||||
Medical condition: End stage renal disease patients with Diabetes Type I and II on Continuous Ambulatory Peritoneal Dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) PT (Prematurely Ended) AT (Completed) IT (Prematurely Ended) CZ (Completed) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005242-23 | Sponsor Protocol Number: NV-NEGRIN-2008-001 | Start Date*: 2009-03-31 |
Sponsor Name:Nicanor Vega Diaz. Hospital Universitario de Gran Canaria Dr Negrin | ||
Full Title: ESTUDIO UNICENTRICO, PROSPECTIVO Y ALEATORIZADO DE COMPARACION DE LOS EFECTOS DE DIFERENTES SOLUCIONES DE DIALISIS PERITONEAL SOBRE LA FUNCIONALIDAD DE LA MEMBRANA PERITONEAL EN PACIENTES INCIDE... | ||
Medical condition: Cambios funcionales de la membrana peritoneal en los pacientes en diálisis peritoneal automatizada que sean asignado a dianeal o physioneal | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Restarted) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003418-42 | Sponsor Protocol Number: WOE_2013_TUE | Start Date*: 2015-03-23 |
Sponsor Name:Wörwag Pharma GmbH & Co. KG | ||
Full Title: Effect of Mg-Orotate administration on cardiocirculatory Performance, the muscular concentration of phosphocreatine and the adaptation of muscle cellular level: A double blind, randomized, placebo-... | ||
Medical condition: Evaluation of cardiocirculatory performance using clinical and relevant muscle laboratory parameters while taking Mg-Orotate and application of workouts | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002072-26 | Sponsor Protocol Number: P150939 | Start Date*: 2016-08-25 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Multicenter randomized placebo controlled trial assessing the efficacy of oral adjuvant magnesium supplementation in the treatment of alcohol withdrawal syndrome. | |||||||||||||
Medical condition: Patients experiencing an alcohol withdrawal syndrome. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003025-22 | Sponsor Protocol Number: 18IA31 | Start Date*: 2019-12-22 | ||||||||||||||||
Sponsor Name:Great Ormond Street Hospital for Children NHS Foundation Trust | ||||||||||||||||||
Full Title: PlasmaLyte Usage and assessment of kidney Transplant Outcomes in children: the PLUTO trial | ||||||||||||||||||
Medical condition: Kidney transplantation in paediatric patients with end-stage kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004718-27 | Sponsor Protocol Number: INRETRAM3/2014 | Start Date*: 2017-01-11 | ||||||||||||||||
Sponsor Name:Medical Unviersity of Warsaw | ||||||||||||||||||
Full Title: A randomised, multicenter, single-blinded, parallel-group study to assess efficacy, safety and tolerability of the combination of Immediate Release (IR) tramadol with micronized magnesium lactate a... | ||||||||||||||||||
Medical condition: Chronic knee and/or hip pain due to Osteoarthritis. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001390-26 | Sponsor Protocol Number: PRO-RENAL-REG-064 | Start Date*: 2004-11-09 | |||||||||||
Sponsor Name:Baxter R&D Europe SCRL | |||||||||||||
Full Title: A Subjective Evaluation of Inflow Pain: Comparison of Extraneal to Extraneal Physiological pH | |||||||||||||
Medical condition: Patients with End Stage Renal Disease (ESRD) undergoing peritoneal dialysis (PD) therapy and experiencing pain on infusion with Extraneal not related to the catheter or volume of dialysis fluid. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DK (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005365-35 | Sponsor Protocol Number: 1449 | Start Date*: 2008-07-20 | |||||||||||
Sponsor Name:Fresenius Medical Care Deutschland GmbH | |||||||||||||
Full Title: Multicentric, parallel, controlled, randomized, single blind clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertension treated with continous ambulatory or... | |||||||||||||
Medical condition: Subjects with renal failure treated with peritoneal dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) FR (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002176-27 | Sponsor Protocol Number: HC-G-H-1505 | Start Date*: 2017-08-30 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Pragmatic, prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of a 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution ... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in trauma surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002162-30 | Sponsor Protocol Number: HC-G-H-1504 | Start Date*: 2017-04-12 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients u... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in elective abdominal surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) AT (Completed) HR (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003175-45 | Sponsor Protocol Number: TRIO 016 | Start Date*: 2009-01-12 | |||||||||||
Sponsor Name:Cancer International Research Group | |||||||||||||
Full Title: A randomized phase II, open-label multicenter trial of panobinostat monotherapy in women with HER2 positive locally recurrent or metastatic breast cancer | |||||||||||||
Medical condition: HER-2 positive locally recurrent or metastatic breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) BE (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000791-42 | Sponsor Protocol Number: JVM-GLU-12 | Start Date*: 2012-07-26 |
Sponsor Name:FUNDACION INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO LA PRINCESA | ||
Full Title: OPEN, RANDOMIZED AND CONTROLLED STUDY OF SAFETY AND VIABILITY, TO EVALUATE THE NEUROPROTECTIVE EFFECT OF PLASMA GLUTAMATE DIALYSIS IN ACUTE ISCHEMIC STROKE. | ||
Medical condition: BRAIN ISCHEMIC STROKE IN ACUTE PHASE | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002695-45 | Sponsor Protocol Number: 15-156 | Start Date*: 2018-05-16 |
Sponsor Name:RWTH Aachen University represented by the Rector, himself, represented by the Dean of the Medical Faculty | ||
Full Title: Effect of Empagliflozin on Cardiac Output in Patients with Acute Heart Failure (EMPA Acute Heart Failure) | ||
Medical condition: Patients with acute heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-000418-23 | Sponsor Protocol Number: AGO/2015/002 | Start Date*: 2015-12-18 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Intraoperative intraperitoneal chemoperfusion to treat peritoneal minimal residual disease in stage III ovarian cancer: a randomized phase II trial. | ||
Medical condition: stage III ovarian cancer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000057-20 | Sponsor Protocol Number: HC-G-H-1209 | Start Date*: 2015-11-10 | ||||||||||||||||
Sponsor Name:B. Braun Melsungen AG | ||||||||||||||||||
Full Title: PROSPECTIVE, RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTI-CENTRIC, INTERNATIONAL, STUDY ON THE EFFICACY AND SAFETY OF AN EARLY TARGET CONTROLLED PLASMA VOLUME REPLACEMENT THERAPY WITH A BALANCED GEL... | ||||||||||||||||||
Medical condition: Hypovolaemia in Severe Sepsis / Septic Shock | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) CZ (Completed) AT (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001872-12 | Sponsor Protocol Number: CL-N-LTX-III/08-ESP/19 | Start Date*: 2021-12-28 | |||||||||||||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||||||||||||
Full Title: A Prospective, randomized, single blind, multicenter Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in liver transplantation | |||||||||||||||||||||||
Medical condition: Liver transplantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001388-23 | Sponsor Protocol Number: PRO-RENAL-REG-062 | Start Date*: 2004-11-09 | |||||||||||
Sponsor Name:Baxter R&D Europe SCRL | |||||||||||||
Full Title: A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD). | |||||||||||||
Medical condition: End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DK (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
